Medicare Enrolled
Dr. Andro Sharobiem, M.D.
Internal Medicine · Riverside, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sharobiem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharobiem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharobiem
Dr. Andro Sharobiem is an internal medicine specialist in Riverside, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sharobiem performed 17,380 Medicare services across 3,135 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharobiem received a total of $10,279 from 57 pharmaceutical and/or device companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharobiem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in CA
$10,279 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,380
Medicare services
Top 1% in CA for internal medicine
3,135
Unique beneficiaries
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~966 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
5,409 | $124 | $500 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
5,384 | $151 | $400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
2,479 | $96 | $500 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
767 | $96 | $225 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
503 | $172 | $1,200 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
494 | $48 | $250 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
483 | $93 | $600 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
409 | $139 | $1,000 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
227 | $146 | $800 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
172 | $85 | $200 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
146 | $0 | $120 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
113 | $107 | $600 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $11 | $60 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
103 | $98 | $350 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
91 | $42 | $200 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
78 | $132 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
77 | $42 | $175 |
| New patient office visit, complex (60-74 min) | 74 | $141 | $350 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
63 | $8 | $25 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
48 | $3 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $91 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
24 | $11 | $100 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
22 | $33 | $80 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $32 | $60 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
20 | $218 | $486 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
16 | $170 | $200 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
12 | $33 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,279
Total received (2018-2024)
Avg $1,468/year across 7 years
Top 10% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
659
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,976 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$303 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$849
2023
$1,787
2022
$1,539
2021
$1,694
2020
$749
2019
$1,597
2018
$2,064
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$102
Novo Nordisk Inc
$78
Otsuka America Pharmaceutical, Inc.
$71
Esperion Therapeutics, Inc.
$67
Astellas Pharma US Inc
$58
Bayer Healthcare Pharmaceuticals Inc.
$55
Almatica Pharma LLC
$46
Lilly USA, LLC
$45
Phathom Pharmaceuticals, Inc.
$43
Novartis Pharmaceuticals Corporation
$36
CeQur Corporation
$24
VIVUS LLC
$23
Abbott Laboratories
$21
Amgen Inc.
$20
SCILEX PHARMACEUTICALS INC.
$18
PFIZER INC.
$18
ABBVIE INC.
$17
Neurocrine Biosciences, Inc.
$17
Corcept Therapeutics
$16
GlaxoSmithKline, LLC.
$16
Lundbeck LLC
$15
Biogen, Inc.
$14
Sumitomo Pharma America, Inc.
$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Top 3 companies account for 29.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$943
AstraZeneca Pharmaceuticals LP
$702
AbbVie Inc.
$666
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$588
Otsuka America Pharmaceutical, Inc.
$519
Astellas Pharma US Inc
$498
Sunovion Pharmaceuticals Inc.
$482
Boehringer Ingelheim Pharmaceuticals, Inc.
$474
PFIZER INC.
$440
GlaxoSmithKline, LLC.
$366
Novartis Pharmaceuticals Corporation
$304
Janssen Pharmaceuticals, Inc
$301
UCB, Inc.
$289
Lilly USA, LLC
$238
Merck Sharp & Dohme LLC
$234
Amgen Inc.
$229
Radius Health, Inc.
$216
Bayer HealthCare Pharmaceuticals Inc.
$209
Allergan Inc.
$201
Merck Sharp & Dohme Corporation
$174
ABBVIE INC.
$168
Abbott Laboratories
$150
Bayer Healthcare Pharmaceuticals Inc.
$142
Biohaven Pharmaceutical Holding Company Ltd.
$141
E.R. Squibb & Sons, L.L.C.
$131
SANOFI-AVENTIS U.S. LLC
$131
Allergan, Inc.
$125
Biohaven Pharmaceuticals, Inc.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$109
Avanir Pharmaceuticals, Inc.
$90
Biogen, Inc.
$74
Esperion Therapeutics, Inc.
$67
Almatica Pharma LLC
$63
MannKind Corporation
$60
Melinta Therapeutics, Inc.
$59
Scilex Pharmaceuticals Inc.
$50
Sumitomo Pharma America, Inc.
$46
NESTLE HEALTHCARE NUTRITION INC.
$46
Phathom Pharmaceuticals, Inc.
$43
IDORSIA PHARMACEUTICALS US INC
$43
Neurocrine Biosciences, Inc.
$40
Boston Scientific Corporation
$32
Lundbeck LLC
$32
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$25
La Jolla Pharmaceutical Company
$24
CeQur Corporation
$24
VIVUS LLC
$23
Eisai Inc.
$19
Regeneron Healthcare Solutions, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$18
Corcept Therapeutics
$16
Daiichi Sankyo Inc.
$14
Amarin Pharma Inc.
$14
Medtronic, Inc.
$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Melinta Therapeutics, LLC
$13
BOSTON SCIENTIFIC CORPORATION
$13
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
ADUHELM · ADVAIR · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · AREXVY · AVYCAZ · Aimovig · BELSOMRA · BREO · BREZTRI · BRILINTA · BYDUREON · Baxdela · Briviact · CAPLYTA · CREON · CeQur Simplicity · DALVANCE · DIFICID · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · EVKEEZA · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GEMTESA · GENERAL PAIN MANAGEMENT · GIAPREZA · INGREZZA · INJECTAFER · INVOKANA · InPen · Infinity DBS Pulse Generators · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQEMBI · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LOREEV XR · LUCEMYRA · LYRICA · LifeVest · MOUNJARO · MYRBETRIQ · NEXLETOL · NUEDEXTA · NURTEC ODT · Nuedexta · Orbactiv · Otezla · Ozempic · PAXLOVID · QSYMIA · QULIPTA · QUVIVIQ · RELISTOR ORAL · REXULTI · Rybelsus · SAMSCA · SEEBRI · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · TEFLARO · TERIPARATIDE · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · UTIBRON · Utibron · VERQUVO · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFIXAN · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
1,166
Per 100K population
47.6
County median income
$89,672
Nearest hospital
PACIFIC GROVE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sharobiem is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sharobiem experienced with nursing facility visit, high complexity?
Based on Medicare claims data, Dr. Sharobiem performed 5,409 nursing facility visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharobiem receive payments from pharmaceutical companies?
Yes. Dr. Sharobiem received a total of $10,279 from 57 companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharobiem's costs compare to other internal medicine physicians in Riverside?
Dr. Sharobiem's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharobiem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Riverside
Browse internal medicine physicians in Riverside ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology